Neoasia Group, incorporated in 1995 and headquartered in Singapore, is the foremost distributor of medical aesthetics and dermatological technologies in Asia. For over 30 years, Neoasia has served as a trusted bridge between global pharmaceutical innovators and regional medical practitioners. In 2026, the group is recognized for its "Science-First" philosophy, managing a prestigious portfolio that includes world-class brands such as Neostrata, IBSA Derma (Profhilo), and Candela. With a robust regional presence across Singapore, Malaysia, Indonesia, Vietnam, and the Philippines, Neoasia transcends traditional distribution by integrating data analytics, clinical education, and AI-driven marketing into its business model. Driven by the mission of "Uplifting Confidence Through Science," the group operates state-of-the-art logistics and technical support centers, ensuring that doctors and clinics have access to the most advanced, safe, and effective tools for skin rejuvenation, body contouring, and regenerative aesthetics